Exxon Mobil’s $60 billion acquisition of Pioneer Natural Resources has received the green light from the FTC, allowing the deal to move forward. However, former Pioneer CEO Scott Sheffield has been barred from Exxon’s board amidst allegations of attempting to collude with OPEC to manipulate oil prices.
The U.S. Federal Trade Commission (FTC) alleged that Sheffield coordinated with U.S. shale oil producers to restrict output and inflate energy prices. According to Reuters, the FTC claimed Sheffield utilized his position to align oil production across the Permian Basin with OPEC+.
Despite the controversy surrounding Sheffield, the approval of the acquisition allows Exxon to finalize the deal on Friday, enabling the company to shift its focus to a dispute with Chevron over its proposed acquisition of Hess Corp. Exxon’s shares saw a 1% increase in morning trading, reaching $117.26.
Related: FTC to Approve Exxon’s $64 Billion Deal with Pioneer Resources
Kyle Mach, Deputy Director of the FTC’s Bureau of Competition, emphasized the inappropriateness of Sheffield’s past conduct for a position on Exxon’s board. However, when questioned about potential criminal implications, the FTC refrained from commenting, stating their obligation to refer such matters to the U.S. Department of Justice.
The approval of Exxon’s acquisition sets a positive precedent for other energy merger reviews, including those involving Chevron, Diamondback Energy, Occidental Petroleum, and Chesapeake Energy, all of which have faced scrutiny from the FTC.
Pioneer expressed surprise at the FTC’s complaint against Sheffield but affirmed its commitment to the deal’s closure. The company argued that Sheffield’s industry commentary, although outspoken, should not disqualify him from a board seat, citing its relevance to public interest.
Source: Reuters
Featured News
Doug Gurr Appointed Interim Chairman of UK’s Competition Authority
Jan 22, 2025 by
CPI
LinkedIn Faces Lawsuit Over Alleged Misuse of Customer Data for AI Training
Jan 22, 2025 by
Amanda Adams
Johns Hopkins and Caltech Settle for $35.3M in College Price-Fixing Lawsuit
Jan 22, 2025 by
CPI
Top Antitrust Expert Joins Cravath from Paul Weiss
Jan 21, 2025 by
CPI
CMA Chief Removed as UK Government Targets Regulatory Overhaul
Jan 21, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Pharmacy Benefit Managers
Jan 20, 2025 by
CPI
Untangling the PBM Mess
Jan 20, 2025 by
Kent Bernard
Using Data, Not Anecdotes, to Analyze Criticisms of Pharmacy Benefit Managers
Jan 20, 2025 by
Dennis Carlton
Vertical Integration and PBMs: What, Me Worry?
Jan 20, 2025 by
Lawton Robert Burns & Bradley Fluegel
The Economics of Benefit Management in Prescription-Drug Markets
Jan 20, 2025 by
Casey B. Mulligan